CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2015	Jun. 30, 2014	Jun. 30, 2015	Jun. 30, 2014
OPERATING EXPENSES
General and administrative	$ 552	$ 222	$ 1,024	$ 674
Research and development	283	1,172	633	1,802
Total operating expenses	835	1,394	1,657	2,476
Interest and other expenses (income), net	(47)	(3)	9	(63)
Loss from operations before taxes	788	1,391	1,666	2,413
Income tax benefit	(36)	0	(198)	0
NET LOSS	752	1,391	1,468	2,413
Less: Net Loss attributable to the noncontrolling interest	0	0	0	0
Net Loss attributable to Capstone Therapeutics Corp. stockholders	$ 752	$ 1,391	$ 1,468	$ 2,413
Per Share Information:
Net loss, basic and diluted, attributable to Capstone Therapeutic Corp. stockholders (in dollars per share)	$ 0.02	$ 0.03	$ 0.04	$ 0.06
Basic and diluted shares outstanding (in shares)	40,885	40,885	40,885	40,885